Skip to content

Drug interactions

Ozanimod + Pazopanib

Severity: Moderate

Ozanimod and Pazopanib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pazopanib prolongs QT and ozanimod can slow heart rate, which together may increase the risk of bradycardia-related arrhythmia. Ozanimod is generally not started in patients on QT-prolonging drugs with arrhythmogenic potential.

What this interaction means in plain words

Ozanimod and Pazopanib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Ozanimod belongs to Central Nervous System; Pazopanib belongs to Oncology.

Evidence level: Low

Why it happens

Additive effects of QT prolongation and S1P-receptor-mediated heart rate slowing.

What to do

Obtain an ECG before starting ozanimod and seek cardiology advice. Monitor heart rate and QTc during initiation.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ozanimod and Pazopanib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ozanimod with Pazopanib?

MediHelp rates the interaction as moderate. Ozanimod and Pazopanib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pazopanib prolongs QT and ozanimod can slow heart rate, which together may increase the risk of bradycardia-related arrhythmia. Ozanimod is generally not started in patients on QT-prolonging drugs with arrhythmogenic potential.

How serious is the interaction between Ozanimod and Pazopanib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain an ECG before starting ozanimod and seek cardiology advice. Monitor heart rate and QTc during initiation.

What other medicines interact with Pazopanib?

MediHelp also lists interactions of Pazopanib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Pazopanib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in